α-Halo Oxime Ethers from Nitronates and Nitro Compounds
300.13 MHz, COSY, HMQC): δ = 2.28 (ddd, J = 13.0, 11.9,
and 11m[11a] (4%). After column chromatography a fraction con-
11.5 Hz, 1 H, 5-Hax), 2.52 (dd, J = 13.0, 8.2 Hz, 1 H, 5-Heq), 3.68 taining both isomers in a ratio of 6.0:1.0 was obtained, which was
(d, J = 9.9 Hz, 1 H, CHBr), 3.82 (s, 3 H, OCH3), 4.02 (d, J = used for analytical purposes. White solid, m.p. 73–81 °C. Rf = 0.7
9.9 Hz, 1 H, CHBr), 4.13 (dd, J = 8.2, 11.5 Hz, 1 H, 4-Hax), 4.97
(d, J = 11.9 Hz, 1 H, 6-Hax), 6.92 (d, J = 8.3 Hz, 2 H, o- 300.13 MHz, COSY, HMQC): δ = 1.27–1.49 (m, 4 H, 7-H, 8-H, 9-
C6H4OCH3), 7.22 (d, J = 8.3 Hz, 2 H, m-C6H4OCH3), 7.33–7.46 H, 10-H), 1.58–1.79 (m, 4 H, 5-H, 8-H, 9-H, 10-H), 1.93 (d, J =
(EtOAc/hexane = 1:1). Major isomer: 1H NMR (CDCl3,
(m, 5 H, o-, m-, p-C6H5) ppm. 13C NMR (CDCl3, 75.47 MHz, 6.8 Hz, 3 H, CH3), 2.06–2.10 (m, 1 H, 7-H), 3.57 (s, 1 H, 4-Heq),
DEPT, HMQC): δ = 31.4 (CH2Br), 34.2 (C-5), 35.7 (C-4), 55.4 3.81 (s, 3 H, H3CO), 4.01 (m, 1 H, 6-H), 4.46 (q, J = 6.8 Hz, 1 H,
(OCH3), 73.9 (C-6), 114.7 (o-C6H4OCH3), 126.6, 128.4, and 128.6 11-H), 6.89 (d, J = 8.6 Hz, 2 H, o-C6H4OCH3), 7.03 (d, J = 8.6 Hz,
(o-, m-, p-C6H5), 129.4 (m-C6H4OCH3), 132.6 (p-C6H4OCH3), 2 H, m-C6H4OCH3) ppm. 13C NMR (CDCl3, 75.47 MHz, HMQC,
139.0 (i-C6H5), 154.2 (C-O), 159.1 (C=N) ppm. C18H18BrNO2
(360.25): calcd. C 60.01, H 5.04, N 3.89; found C 59.89, H 4.90, N
4.02.
DEPT): δ = 20.0, 24.8, and 27.2 (C-8, C-9, C-10), 21.6 (CH3), 29.2
(C-7), 38.5 (C-5), 43.6 (C-4), 47.3 (C-11), 55.3 (OCH3), 69.3 (C-6),
114.4 (o-C6H4OCH3), 129.2 (m-C6H4OCH3), 133.2 (p-C6H4OCH3),
155.1 (C-O), 158.9 (C-3) ppm. Minor isomer: 1H NMR (CDCl3,
300.13 MHz, COSY, HMQC): δ = 1.27–1.49 (m, 4 H, 7-H, 8-H, 9-
H, 10-H), 1.44 (d, J = 7.1 Hz, 3 H, CH3), 1.58–1.79 (m, 4 H, 5-H,
8-H, 9-H, 10-H), 2.06–2.10 (m, 1 H, 7-H), 3.63 (s, 1 H, 4-Heq), 3.81
(s, 3 H, H3CO), 4.12 (m, 1 H, 6-H), 4.46 (q, J = 7.1 Hz, 1 H, 11-
H), 6.89 (d, J = 8.6 Hz, 2 H, o-C6H4OCH3), 7.05 (d, J = 8.6 Hz, 2
H, m-C6H4OCH3) ppm. 13C NMR (CDCl3, 75.47 MHz, HMQC,
DEPT): δ = 19.3, 25.1, 29.4, and 29.7 (C-7, C-8, C-9, C-10), 21.6
(CH3), 38.1 (C-5), 41.3 (C-4), 51.1 (C-11), 55.3 (OCH3), 68.9 (C-6),
114.1 (o-C6H4OCH3), 129.2 (m-C6H4OCH3), 133.9 (p-C6H4OCH3),
155.1 (C-O), 158.9 (C-3) ppm. C17H22BrNO2: C, 57.96; H, 6.29; N,
3.98; found C, 58.35; H, 6.49; N, 3.93.
(1R,2S,4S,4ЈS)-3Ј-(Bromomethyl)-3,3-dimethyl-4Ј-phenyl-4Ј,5Ј-di-
hydrospiro[bicyclo[2.2.1]heptane-2,6Ј-[1,2]oxazine] (1i): Yield 76%
(procedure i), 90% (procedure ii). White solid, m.p. 117–121 °C
(with dec.), recrystallized from hexane. Rf = 0.8 (EtOAc/hexane
= 1:1). [α]D = –6.6 (c = 1.0, CHCl3, 27 °C). 1H NMR (CDCl3,
300.13 MHz, COSY, HMQC, NOESY): δ = 0.91 (s, 3 H, CH3),
1.16 (s, 3 H, CH3), 1.20 (d, J = 10.3 Hz, 1 H, 7-H), 1.28–1.43 (m,
2 H, 6-H), 1.53–1.64 (m, 2 H, 5-H), 1.84 (dd, J = 13.9, 12.6 Hz, 1
H, 5Ј-HЈax), 1.85 (s, 1 H, 4-H), 2.19 (d, J = 10.3 Hz, 1 H, 7-H),
2.33 (dd, J = 13.9, 7.2 Hz, 1 H, 5Ј-HЈЈeq), 2.46 (d, J = 3.8 Hz, 1 H,
1-H), 3.65 (d, J = 9.8 Hz, 1 H, 8-H), 3.73 (dd, J = 12.6, 7.2 Hz, 1
H, 4Ј-Hax), 3.98 (d, J = 9.8 Hz, 1 H, 8-H), 7.26 (d, J = 7.4 Hz, 2
H, o-C6H5), 7.34 (t, J = 6.7 Hz, 1 H, p-C6H5), 7.39 (dd, J = 7.4,
6.7 Hz, 2 H, m-C6H5) ppm. 13C NMR (CDCl3, 75.47 MHz,
HMQC, DEPT): δ = 22.3 and 24.2 (2 CH3), 22.4 and 23.8 (C-5
and C-6), 31.3 (C-5Ј), 31.8 (C-8), 34.6 (C-7), 39.1 (C-4Ј), 43.2 (C-
1), 44.6 (C-3), 49.3 (C-4), 87.8 (C-2), 127.6, 128.2, and 129.2 (o-,
m-, p-C6H5), 139.3 (i-C6H5), 156.0 (C-3Ј) ppm. Characteristic 2D
NOESY correlations: o-C6H5/5Ј-HЈax, 5Ј-HЈЈeq/6-H, 4Ј-Hax/1-H, 5-
Methyl 3-(Bromomethyl)-5-methyl-4,5-dihydroisoxazole-5-carboxyl-
ate (1n): Yield 84% (procedure i), 68% (procedure ii). Colorless oil.
1
Rf = 0.7 (EtOAc/hexane = 1:1). H NMR (CDCl3, 300.13 MHz): δ
= 1.66 (s, 3 H, CH3), 3.03 (d, J = 17.3 Hz, 1 H, CH), 3.60 (d, J =
17.3 Hz, 1 H, CH), 3.81 (s, 3 H, OCH3), 4.11 (d, J = 11 Hz, 1 H,
CHBr), 4.18 (d, J = 11 Hz, 1 H, CHBr) ppm. 13C NMR (CDCl3,
75.47 MHz, DEPT): δ = 23.1 (CH2), 23.4 (CH3), 44.5 (CH2Br),
53.0 (OCH3), 87.0 (C-O), 155.0 (C=N), 171.9 (C=O) ppm. FTIR
H/CH . FTIR (KBr): ν = 2939 (s, sh), 2860 (s), 1593 (s), 1493 (s),
˜
3
(neat): ν = 3031 (w), 2986 (m), 2956 (m), 2847 (w), 1741 (s), 1615
˜
1455 (s), 1423 (s), 1388 (m), 1366 (m), 1207 (s), 1093 (m), 1023 (s),
973 (s), 952 (s), 931 (m), 907 (s), 777 (s), 757 (s), 704 (s), 655 (m),
603 (m), 526 (s) cm–1. HRMS: calcd. for [C19H25BrNO]+
362.1114 and 364.1094; found 362.1110 and 364.1095.
C19H24BrNO (362.31): calcd. C 62.99, H 6.68, N 3.87; found C
63.09, H 6.57, N 4.07.
(m), 1435 (s, sh), 1378 (m), 1350 (m), 1304 (s), 1206 (s), 1175 (s),
1135 (m), 1104 (m), 986 (m), 918 (s), 850 (m), 767 (m), 672 (m),
625 (m) cm–1. HRMS: calcd. for [C7H11BrNO3]+ 235.9917 and
237.9900; found 235.9920 and 237.9902. C7H10BrNO3 (236.06):
calcd. C 35.62, H 4.27, N 5.93; found C 35.81, H 4.24, N 6.00.
3-(Bromomethyl)-5-(4-bromophenyl)-4,5-dihydroisoxazole (1o):
rel-(4S,4aR,5R,8S,8aR)-3-(Bromomethyl)-4-phenyl-4a,5,6,7,8,8a-
hexahydro-4H-5,8-methano-1,2-benzoxazine (1l): Yield 84% (pro-
cedure ii), m.p. 114–117 °C (with dec.), recrystallized from hexane.
Rf = 0.8 (EtOAc/hexane = 1:1). 1H NMR (CDCl3, 300.13 MHz,
COSY, HSQC, NOESY): δ = 1.07–1.18 (m, 2 H, 6-Hendo and 7-
Hendo), 1.22 (d, J = 10.5 Hz, 1 H, 9-HЈ), 1.47 (m, 1 H, 6-Hexo), 1.62
(m, 1 H, 7-Hexo), 2.04 (d, J = 4.0 Hz, 1 H, 5-H), 2.12 (d, J =
10.5 Hz, 1 H, 9-HЈЈ), 2.20 (dd, J = 10.1, 6.8 Hz, 1 H, 4a-Hax), 2.57
(d, J = 4.9 Hz, 1 H, 8-H), 3.30 (d, J = 10.1 Hz, 1 H, 4-Hax), 3.80
(d, J = 6.8 Hz, 1 H, 8a-Heq), 3.87 (d, J = 10.2 Hz, 1 H, 10-H), 3.91
(d, J = 10.2 Hz, 1 H, 10-H), 7.28–7.43 (m, 5 H, o-, m-, p-
C6H5) ppm. 13C NMR (CDCl3, 75.47 MHz, HSQC): δ = 24.6 (C-
7), 28.5 (C-10), 29.0 (C-6), 33.4 (C-9), 40.3 (C-5), 42.1 (C-4), 42.3
(C-8), 53.4 (C-4a), 83.1 (C-8a), 127.6, 128.7, and 129.7 (o-, m-, p-
C6H5), 137.2 (i-C6H5), 171.0 (C-3) ppm. Characteristic 2D NOESY
correlations: 4a-Hax/8a-Heq, 4-Hax/o-C6H5, 8a-Heq/8-H, 4-Hax/5-H,
Yield 69 % (procedure ii). White solid, m.p. 48–50 °C (pentane/
1
Et2O = 5:1). Rf = 0.65 (EtOAc/hexane = 1:1). H NMR (CDCl3,
300.13 MHz): δ = 3.10 (dd, J = 17.1, 8.2 Hz, 1 H, HC), 3.56 (dd,
J = 17.1, 11.1 Hz, 1 H, HC), 4.21 (s, 2 H, CH2Br), 5.63 (dd, J =
11.1, 8.2 Hz, 1 H, HC), 7.22 (d, J = 8.3 Hz, 2 H, C6H4Br), 7.52 (d,
J = 8.3 Hz, 2 H, C6H4Br) ppm. 13C NMR (CDCl3, 75.47 MHz,
DEPT): δ = 23.4 and 42.7 (CH2 and CH2Br), 82.6 (CH), 122.4 (p-
C6H4Br), 127.5 and 132.0 (o-C6H4Br and m-C6H4Br), 139.3 (C-
Br), 154.6 (C=N) ppm. C10H9Br2NO (319.00): calcd. C 37.65, H
2.84, N 4.39; found C 37.70, H 2.77, N 4.24.
3-(Bromomethyl)-4-phenyl-4,5-dihydroisoxazole (1p): Yield 53 %
(procedure ii). Colorless oil. Rf = 0.8 (EtOAc/hexane = 1:1). 1H
NMR (CDCl3, 300.13 MHz): δ = 3.68 (d, J = 10.9 Hz, 1 H, CHBr),
4.26 (d, J = 10.9 Hz, 1 H, CHBr), 4.43 (dd, J = 8.0, 7.1 Hz, 1 H,
CH-C6H5), 4.64 (d, J = 11.0, 7.1 Hz, 1 H, CHO), 4.78 (d, J = 11.0,
8.0 Hz, 1 H, CHO), 7.21–7.45 (m, 5 H, o-, m-, p-C6H5) ppm. 13C
NMR (CDCl3, 75.47 MHz, DEPT): δ = 22.3 (CH2Br), 53.6 (CH),
77.8 (CH2O), 127.6, 128.2, and 129.4 (o-, m-, p-C6H5), 137.5 (i-
C6H5), 157.6 (C=N) ppm. C10H10BrNO (240.10): calcd. C 50.02,
H 4.20, N 5.83; found C 49.96, H 4.24, N 5.94.
8a-Heq/7-Hendo
,
4a-Hax/6-Hendo
,
4-Hax/9-HЈЈ, 4a-Hax/o-C6H5.
C16H18BrNO (320.23): calcd. C 60.01, H 5.67, N 4.37; found C
60.21, H 5.73, N 4.38.
rel-(4S,4aR,8aR)-3-(1-Bromoethyl)-4-(4-methoxyphenyl)-
4a,5,6,7,8,8a-hexahydro-4H-1,2-benzoxazine (1m): Obtained by
procedure ii from nitronate 2m as a mixture of two isomers in a
ratio of 2.0:1.0 (yield 56%) accompanied by products 10m[11a] (5%)
3-(Iodomethyl)-6,6-dimethyl-4-phenyl-5,6-dihydro-4H-1,2-oxazine
(1r): Yield 90% (procedure i). White solid, m.p. 100–103 °C (hex-
Eur. J. Org. Chem. 2014, 8148–8159
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
8155